Gensight Biologics (France) Price on December 2, 2024
| SIGHT Stock | EUR 0.31 0.01 3.13% |
If you're considering investing in Gensight Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gensight Biologics stands at 0.31, as last reported on the 11th of December 2024, with the highest price reaching 0.32 and the lowest price hitting 0.31 during the day. Gensight Biologics holds Efficiency (Sharpe) Ratio of -0.0519, which attests that the entity had a -0.0519% return per unit of risk over the last 3 months. Gensight Biologics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gensight Biologics' Risk Adjusted Performance of (0.01), market risk adjusted performance of (1.29), and Standard Deviation of 4.76 to validate the risk estimate we provide.
Gensight Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gensight |
Sharpe Ratio = -0.0519
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SIGHT |
Estimated Market Risk
| 4.77 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gensight Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gensight Biologics by adding Gensight Biologics to a well-diversified portfolio.
Gensight Biologics Valuation on December 2, 2024
It is possible to determine the worth of Gensight Biologics on a given historical date. On December 2, 2024 Gensight was worth 0.37 at the beginning of the trading date compared to the closed value of 0.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gensight Biologics stock. Still, in general, we apply an absolute valuation method to find Gensight Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gensight Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gensight Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 0.32 | 0.37 | 0.32 | 0.37 | 1,603,911 | |
12/02/2024 | 0.37 | 0.37 | 0.32 | 0.33 | 591,403 |
| 0.33 | 0.33 | 0.31 | 0.32 | 378,490 |
| Backtest Gensight Biologics | | | Gensight Biologics History | | | Gensight Biologics Valuation | Previous | Next |
Gensight Biologics Trading Date Momentum on December 2, 2024
| On December 03 2024 Gensight Biologics SA was traded for 0.32 at the closing time. The highest price during the trading period was 0.33 and the lowest recorded bid was listed for 0.31 . The volume for the day was 378.5 K. This history from December 3, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 3.03% . The overall trading delta to the current price is 3.03% . |
Gensight Biologics Fundamentals Correlations and Trends
By evaluating Gensight Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gensight Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gensight financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gensight Biologics Stock history
Gensight Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gensight is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gensight Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gensight Biologics stock prices may prove useful in developing a viable investing in Gensight Biologics
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France. GENSIGHT BIOLOGICS is traded on Paris Stock Exchange in France.
Gensight Biologics Stock Technical Analysis
Gensight Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gensight Biologics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Gensight Biologics SA cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gensight Biologics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Gensight Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gensight Biologics shares will generate the highest return on investment. By undertsting and applying Gensight Biologics stock market strength indicators, traders can identify Gensight Biologics SA entry and exit signals to maximize returns
Gensight Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gensight Biologics' price direction in advance. Along with the technical and fundamental analysis of Gensight Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gensight to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | (1.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.